<SEC-DOCUMENT>0000950142-13-002383.txt : 20131205
<SEC-HEADER>0000950142-13-002383.hdr.sgml : 20131205
<ACCEPTANCE-DATETIME>20131205142337
ACCESSION NUMBER:		0000950142-13-002383
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20131204
FILED AS OF DATE:		20131205
DATE AS OF CHANGE:		20131205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TECK RESOURCES LTD
		CENTRAL INDEX KEY:			0000886986
		STANDARD INDUSTRIAL CLASSIFICATION:	MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13184
		FILM NUMBER:		131259623

	BUSINESS ADDRESS:	
		STREET 1:		550 BURRARD ST
		STREET 2:		SUITE 3300, BENTALL 5
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C 0B3
		BUSINESS PHONE:		604 699-4000

	MAIL ADDRESS:	
		STREET 1:		550 BURRARD ST
		STREET 2:		SUITE 3300, BENTALL 5
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C 0B3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TECK COMINCO LTD
		DATE OF NAME CHANGE:	19940623
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>eh1301313_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html>
<head>
    <title>eh1301313_6k.htm</title>
    <!--Licensed to: Paul Weiss-->
    <!--Document Created using EDGARizer 2020 5.4.5.0-->
    <!--Copyright 1995 - 2013 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">UNITED STATES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Washington, D.C. 20549</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">FORM 6-K</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REPORT OF FOREIGN PRIVATE ISSUER</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pursuant to Rule 13a-16 or 15d-16 of the</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Securities Exchange Act of 1934</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Dated:&#160;&#160;December 4, 2013 </font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Commission File Number: 001-13184</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TECK RESOURCES LIMITED</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Suite 3300 &#8211; 550 Burrard Street, Vancouver, British Columbia&#160;&#160;V6C 0B3</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">(Address of principal executive offices)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Form 20-F ____&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form 40-F <font style="DISPLAY: inline; TEXT-DECORATION: underline">&#160;&#160;&#160;X&#160;&#160;&#160;</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____<font id="TAB1" style="MARGIN-LEFT: 12pt"></font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
<font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURE</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Teck Resources Limited</font></font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-WEIGHT: normal">(Registrant)</font></font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">Date:&#160;&#160;&#160; December 4, 2013</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">By: </font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">/s/&#160;Karen L. Dunfee</font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">Karen L. Dunfee</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">Corporate Secretary</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="33%"><img src="header1.jpg" alt="graphic"></td>
<td width="33%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="33%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<img src="header2.jpg" alt="graphic"></font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="73%"><font style="FONT-FAMILY: arial; FONT-SIZE: 10pt"><font style="FONT-FAMILY: arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">For Immediate Release</font></font></font></td>
<td width="27%"><font style="FONT-FAMILY: arial; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold">December 4, 2013</font></font></td>
</tr><tr>
<td width="73%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">13-38-TR</font></font></div>
</td>
<td width="27%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Zinc Alliance for Child Health Funds $1.5 Million Project</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">to Save Children&#8217;s Lives in India</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Ahmedabad, India &#8211; Today, Canadian partners in the Zinc Alliance for Child Health (ZACH)&#8212;Teck, the Micronutrient Initiative (MI) and the Government of Canada&#8212;announced $1.5 million in funding to expand a childhood diarrhea treatment program in the Indian state of Gujarat. This funding will support the State Government to scale up the program to all 26 districts in Gujarat and train an additional 97,000 health care workers on the proper treatment of diarrhea using zinc and oral rehydration salts (ORS).</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">No life-threatening childhood illness affects more children than diarrheal disease. In India, approximately 230,000 children die annually as a result of dehydration, weakened immunity or malnutrition associated with diarrhea. Using zinc, along with ORS, to treat diarrhea not only strengthens the immune system to accelerate recovery, but can save lives.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#8220;The ZACH partnership is committed to reducing child mortality by accelerating the use of zinc supplements and ORS to treat diarrhea, one of the most common killers of children in India,&#8221; said M.G. Venkatesh Mannar, President of the Micronutrient Initiative. &#8220;We are pleased to support the State of Gujarat&#8217;s Diarrhea Alleviation through Zinc and ORS Therapy (DATZ) project that aims to improve the chances of survival for their children.&#8221;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">The DATZ project currently operates in six districts of Gujarat and has already reached 270,000 children. ZACH, a public-private-civil society alliance, will provide funding for an additional 20 districts, reaching 670,000<font style="DISPLAY: inline; FONT-FAMILY: Arial; COLOR: #1f497d">&#160;</font>children by March of 2016. The project builds on the success of ZACH&#8217;s current zinc projects in Africa that have helped treat over five million children since its launch in 2011.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#8220;I congratulate the Government of India and the State Government of Gujarat in their efforts to save and improve the lives of India&#8217;s children,&#8221; said the Honourable Christian Paradis, Minister of International Development and Minister for <font style="FONT-STYLE: italic; DISPLAY: inline">La Francophonie</font>. &#8220;Canada is focused on improving the lives of children and youth around the world because the world's future depends on their health and well-being. ZACH, with support from Canada&#8217;s Muskoka Initiative, works to scale up high impact and cost-effective health solutions.&#160;&#160;After the successful launch of projects in countries throughout Africa, the Government of Canada is pleased to see the expansion of ZACH in India.&#8221;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#8220;As one of the world&#8217;s largest producers of zinc, Teck is committed to addressing the problem of global zinc deficiency,&#8221; said Teck Senior Vice President Doug Horswill.&#160;&#160;&#8220;Since 2011, nearly 270,000 children have benefitted from zinc and ORS supplied by the Gujarat government health service delivery system. This new ZACH funding will help expand an already successful diarrhea treatment project, increasing access to this life-saving treatment for the more than 1 million children under the age of five in Gujarat.&#8221;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="33%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="33%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="33%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<img src="footer.jpg" alt="graphic"></font></td>
</tr></table>

&#160;</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="33%"><img src="header1.jpg" alt="graphic"></td>
<td width="33%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="33%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<img src="header2.jpg" alt="graphic"></font></td>
</tr></table>
</div>

<div><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">MI&#8217;s efforts in Gujarat focus on training and supervising health workers and caregivers, as well as supporting the development of social marketing materials to increase awareness of zinc and ORS as an effective diarrhea treatment.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">ZACH funding will also support the development of supportive supervision of front-line health workers. This includes personalized one-on-one exercises that reinforce skills development through meetings, joint field visits, reviews and refresher training.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About the Micronutrient Initiative</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">The Micronutrient Initiative is an Ottawa-based, international not-for-profit organization dedicated to ensuring that the world's most vulnerable&#8212;especially women and children&#8212; in developing countries get the vitamins and minerals they need to survive and thrive through supplementation and food fortification programs. Its mission is to be a global leader in advancing integrated, innovative and sustainable solutions to reduce vitamin and mineral deficiencies through advocacy, technical and programmatic support, in collaboration with others. With Canadian support, the organization is saving and improving the lives of 500 million people annually in more than 70 countries with its child survival, child health, growth and development, and women&#8217;s and newborn survival and health programs.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About Teck</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Teck is a diversified resource company committed to responsible mining and mineral development with major business units focused on copper, steelmaking coal, zinc and energy. The pursuit of sustainability guides Teck&#8217;s approach to business. As one of the world&#8217;s largest producers of zinc, Teck is committed to raising awareness and helping solve the global health issue of zinc deficiency. Its Zinc &amp; Health program includes partnerships with UNICEF, Free The Children, the Micronutrient Initiative, the Government of Canada and other organizations. To learn more about Teck&#8217;s Zinc &amp; Health program<font style="DISPLAY: inline; FONT-FAMILY: Arial">,</font> visit <font style="DISPLAY: inline; COLOR: #0000ff; TEXT-DECORATION: underline">www.zincsaveslives.com</font><font style="DISPLAY: inline; FONT-FAMILY: Arial; COLOR: #0000ff; TEXT-DECORATION: underline">.</font> Teck is headquartered in Vancouver, Canada, and its shares are listed on the Toronto Stock Exchange under the symbols TCK.A and TCK.B and the New York Stock Exchange under the symbol TCK.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About the Department of Foreign Affairs, Trade and Development, Canada</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Foreign Affairs, Trade and Development Canada (DFATD) leads Canada's international effort to help people living in poverty. DFATD&#8217;s aim is to manage Canada's support and resources effectively and accountably to achieve meaningful, sustainable results. It also engages in policy development in Canada and internationally, enabling Canada's effort to realize its development objectives.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Information:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Aynsley Morris</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Micronutrient Initiative&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Telephone: 613-782-6831</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Mobile: 613-218-8427</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Email<font style="DISPLAY: inline; FONT-FAMILY: Arial">: </font><font style="DISPLAY: inline; COLOR: #0000ff; TEXT-DECORATION: underline">amorris@MICRONUTRIENT.ORG</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="33%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="33%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="33%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<img src="footer.jpg" alt="graphic"></font></td>
</tr></table>

&#160;<br>
</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="33%"><img src="header1.jpg" alt="graphic"></td>
<td width="33%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="33%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<img src="header2.jpg" alt="graphic"></font></td>
</tr></table>
</div>

<div><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Chris Stannell</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Teck</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Telephone: 604-699-4368</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Email: <font style="DISPLAY: inline; COLOR: #0000ff; TEXT-DECORATION: underline">chris.stannell@teck.com</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Margaux Stastny, Director of Communications</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Office of the Minister of International Development and Minister for La Francophonie</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Telephone: 819-953-6238</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Email: <font style="DISPLAY: inline; COLOR: #0000ff; TEXT-DECORATION: underline">margaux.stastny@international.gc.ca</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Media Relations Office</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Foreign Affairs, Trade and Development Canada (DFATD)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Telephone: 819-995-1874</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Email: <font style="DISPLAY: inline; COLOR: #0000ff; TEXT-DECORATION: underline">media@international.gc.ca</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Follow us on Twitter: <font style="DISPLAY: inline; COLOR: #0000ff; TEXT-DECORATION: underline">@DFATDCanada</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="33%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="33%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="33%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<img src="footer.jpg" alt="graphic"></font></td>
</tr></table>

&#160;</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<hr style="COLOR: black" align="center" noshade size="2" width="100%">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>header1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 header1.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`@$!
M`@("`@("`@(#!0,#`P,#!@0$`P4'!@<'!P8'!P@)"PD("`H(!P<*#0H*"PP,
M#`P'"0X/#0P."PP,#/_;`$,!`@("`P,#!@,#!@P(!P@,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`$8`
M>P,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/W\H)Q17X_?\'77Q]\>?`[_`(4+_P`(3XV\7^#?[4_X2'[;_8>L
MW.G?;/+_`++\OS/)==^W>^W=G&]L8R:`/V!I-PK^/X?M]?'<?\UM^+W_`(66
MH_\`QZC_`(;[^.__`$6WXO?^%EJ/_P`>H`_L!W"C>,U_']_PWW\=_P#HMOQ>
M_P#"RU'_`./5^MW_``:TWWQ0^._BKXE?$;QU\0/B!XJT+1;>#P[I=KK7B&\O
M[4W4I$]PXCED91)'&D`#8R!<,!U-`'[*4444`%%%%`!5/Q!KUKX6T&]U.^E\
MBQTZ![FXDVEO+C12S-A02<`$X`)JY7%?M)_\FZ^/O^Q=U#_TFDH`\!M_^"Y?
M[+-U-'''\4-SRL$4?\(WJ_))P/\`EUKZS!R*_BQ\)H$\5:7@?\O</_H8K^TY
M?NT`%%%%`!7$_&+]FKX=?M#_`-F_\)]X#\&^-_['\W[!_;VBVVI?8O-V>9Y7
MG(VS?Y<>[;C.Q<YP*[:B@#P7Q-_P3:_9WM_#M_)'\!_@VKK;R%6'@S3LJ=IY
M'[FOY&$_X]1[BO[4?%G_`"+&H_\`7M)_Z`:_BN3_`(]5^@H`_J[_`&8/^"=G
M[/\`X@_9J^'M]??`_P"$5Y?7OAK39[BXG\'Z?)+/(]K&S.S&'+,2223R:\W_
M`&T/^"I/[.G_``1E\,MX/\-^&M#;Q)=S&\_X0OP;9VVGK!(Z+^_NO+58X-RJ
M@RRM(PV$*5&1Z)\6/VJ8?V*/^"0EM\3)%CDNO#/@#36T^*3[LU[+;006J,.N
MTSR1AL<[<U_-U^S)\"_&_P#P4X_;9TKPJNK37OBSXAZI/?:IK%[F7R1A[BZN
MI,8SM178*,;FVJ",C`!^F-O_`,'@>J'65,GP#L?[/W<JOB]O."Y_O?8\9Q[5
M^A/_``30_P""QOPM_P""F6FWEGX>:Z\->--+3S;WPUJCI]J\K@&>!U.V:($@
M%AAE.-RKE2?"-2_X-:/V<9/A#-HUI<^-H?$QM2L/B*74_,E2?;P[6X40LF[D
MH%!(XW`_-7XD6EUXZ_X)1?\`!0-O*NHX_&'PE\1F*22V<B#4(T;#KR`?)N(&
M(((!VR]C0!_7&3@5\4_\%'?^"ZWP?_X)W:NWARZ>\\<^/%_UN@:*Z;M/&W(^
MU3,=D.01A<-)@@[`I#5!_P`%6?\`@J%;_LP?\$P[/XK>!;Y1K?Q*MK*W\'SR
M1I(8GO8?M`N&1LJ3';K(X!#+O"`@@XK^=+]G?]G[Q_\`M_?M,6/A+PW'/KWC
M+QC>RW-S=WDY*J26EN+NXE.3M4%G9N6).`&9@I`/U,G_`.#P'5O[59H_@)I_
MV'=PC>+W\W&>[?8\9Q[5]P?L@?\`!5'P]_P5*_8J^+FN:+X5UKPG>>%]'N[+
M4;2^FCN(M\EG*ZF&9,%UPISN1"#CCG-?/OPM_P"#2WX.V'PVMK?QEX^^(>J>
M+'B_TF^TF6UL;..0CI%#)!*VT>KN2>OR]![;^Q'_`,$N?^'7/[)?Q^\/P^*?
M^$LT[Q1!>ZEI]S):?9IX(%T]D$<J@E2X;=\RD!A@[5Z4`?S2^%/^1GTS_KZB
M_/>*_M+:18HBS,%51DD]`*_BU\)C=XHTW_KZB/\`X\*_:#_@X!_X+G2VDVO?
M`/X.ZEM8!].\8>([64'J-LFGVS#OR5EDZCE%YW&@#W']IG_@Z.^$/P%^..O>
M#]$\*>(/B!9Z#/\`96UO2KVW2QNI0!Y@A+'+JK97>.&*DC*[6/0_#S_@O;XH
M^+?@RQ\1^&/V3/CMKF@ZHADL[^RL3<6]RH8J61TC*L-RD9!/2OS(_P""(?\`
MP16U;]OWQQ9^.O'%G<:?\&]%NB)F9VBF\2S1GFUAQAA$&XDE!&,%$.XL8_Z0
M?#GA;3?"'AZQTG2[&UL--TRWCM;2UMXA'#;1(H5(T4<*JJ``!P`!0!H4444`
M9_BS_D6-1_Z]I/\`T`U_%>AS:K[@5_:AXL_Y%C4?^O:3_P!`-?Q7)_QZ+]!0
M!^_W_!>75KK3O^"#?PP@MPWDZA+X9M[K&?\`5BP>49_[:1Q]:_#3X)_'KQI^
MSAXT_P"$B\!>)-8\)Z]Y#VHO],G,-P(GQN0,.<':,_2OZ//^"@O[+]_^UG_P
M0LC\.Z/;R76O:;X+T?7M,AC0O)--9P03M&BCEGDB66-0.[BOP?\`^"5?[;L7
M_!/W]MCPK\1+^SGU'P_$)M-URWA`\V2RG7:[(#U>-MDH4X#&,+D9R`!W_#W3
M]I\?\UT^*'XZQ+_C7B?Q3^*?B;XW>/M0\5>+M7U3Q)XDU9E>\U&_<S7%T518
MU+L>3A$51[**_J^^'_\`P4N_9O\`B7X3@UG2_C1\+/L<R!B+O7[6QGBXSB2&
M=DDC/LZ@UY;\8O\`@N1^SC\/OB!X3\(^&_%FF_$?Q-XNURRT2"V\-LMW;6GV
MF=(O/FNA^Y$:[\D*S.>,+C)`!^1?_!5[Q)J$W_!)+]A/3YFF:UFT'5Y)"SDC
M=!]BBA'U6-V`]!7KG_!HMX7TN_\`VD_B[JUPJMK&G^&[2VLR1R()KDM-@_[T
M$%?6G_!T5^RC??&_]@S2?&VCVLEQJ'PKU;^T+J.*+<RZ=<)Y5PP`YPCBW=CT
M"(Y/3C\<_P#@DM_P43NO^":?[65KXXDTV?6O#NJ64FC:]I\,HCEFM)'1_,CS
M\OFQO&CJ#@,`R[E#E@`?U@5Q?[27_)NWCW_L7=0_])I*\7\(_P#!9?\`9<\8
M>#(-<B^.'P^L[>>/S/L]_J:V5['QDJUO+ME##IC;^=9_@S_@HW\+_P!O+X1?
M'33_`(8ZM=>(++P'X?DBOM4^R/;VEQ)<VMV56'S,.X7R&RQ0*<C:6'-`'\J>
MGP375W#';AC-(ZK&`=IW$X'/:MBYT6;X;_$V;3?%6BW+7.@ZH;?6-)N&:UG+
MPR[9[=VQNC;*LA(&5/.,U1\)\>)]+_Z^X?\`T-:_:?\`X.6/^"2DFJ+??M'?
M#^Q7S;>)%\:Z7;6YW2J#M&IKM[J"BRC'W5$AZ2&@#]2/V#OC+\._CW^RAX)\
M2?"NWM;'P3<:9%;V%A!&(AI0B'EM:,@^Z\3*R$=R,@D$$^OU_,?_`,$+?^"J
MMY_P3X_:*M]!\3:A<-\)_&MPEMK$$DI,.C7#%534D7.!MP%EQRT7/S&-!7]-
M6FZC!J^GP75K-#<VMU&LL,T3AXY4895E8<$$$$$=<T`34444`4]?M)-0T2\@
MCQYDT+QKGIDJ0*_G47_@U3_:<$2K_:7PJX&,_P!NW/\`\BU_1O10!R7P'\%W
MGP[^!_@_P[J7DM?:#H=EIUR8FW1M+#`D;%20,KN4X)`XK\J/^"IO_!LHGQC\
M=ZAX\^`-]I&@ZEJTLEUJGA?4I&AL99G8LTEI(JMY)8DYB8;,GY6086OV$HH`
M_E_N_P#@W/\`VPX+WR8_A/;SQ`X$R^*='6/'KAKH-^E>]?L4_P#!LE^T!'\9
M_"GB?QUJ7A/P#IWAW5[75)(_MO\`:E_(8)DE"HD/[KG9C)F&,YP>E?T#44`5
M]2TJVUK2[BRO;>"[M+J-H9H9HQ)',C`JRLIR"I!((/!!K\3?^"C?_!K=K>L?
M$F_\4?L]:AHL>B:DQGE\*ZM<M;M82$DLMI/M96B)/"2E2G(#,,`?MU10!_,"
MO_!N9^V%)J/D-\*K=82<&X/BG2#'^7VK=_X[7ZD?\$9/^"0_Q2_8*_9\^-FE
M^-]0\+RZQ\5=+@M;&PTZYDG&GR10WL?[^4QJN6-RO";@`A.3G%?IM10!_.KH
M7_!K)^TSINM6=Q)J'PM:.WG21MNN7);`8$X'V7K7]#VN:#9^*="NM-U&UM[V
MQU"![:YMYXQ)%/$ZE71E/#*5)!!X(-7**`/P+_:G_P"#5SXK3_M`>)KCX2ZI
MX'_X5]=7C7.C0ZQJMQ#>6<+X;R'Q!)N\MBR!MY+*JL<$D5]#?`S]D+_@II^S
MO\(]!\$>'?B)\(/[!\,VHLM/6\N&NIHH%)V1^8]F6*H"%4$\*JCH*_6ZB@`H
AHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/_9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>header2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 header2.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`@$!
M`@("`@("`@(#!0,#`P,#!@0$`P4'!@<'!P8'!P@)"PD("`H(!P<*#0H*"PP,
M#`P'"0X/#0P."PP,#/_;`$,!`@("`P,#!@,#!@P(!P@,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`$X`
MR@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/W\H)Q17G_[1"_$:\\&+9?#-O#MGKE\S1-J.LAY(-.0C'F+$F#(
MX)R`3CCGK4RERJYMAZ/M:BI\RC?JW9+S9L?%;XV>$?@7X9DUGQCXBTCPWI<?
M6XU"Y6%6/HH)RQ]@":^5_$O_``<!?LL^'+UH5^(G]I;207L["9TX]V"US_\`
MPXE\(_&;Q&?$GQV\=^-OBYXDF`+_`&J_:TL8<?=6.&/`"KR`#SS4WQ/_`.#=
M7]F7X@^$[G3['PK>>&[R2,K!?Z?>NLMN_9MI^5L>C<&O+K5,QEK1C%+S;;_#
M1'WF6X3@ZBU#,:]:I+JZ<8Q@O3F]Y^MEZ'L7[,'_``58^`_[8'BM=`\#^/-/
MOM?D0R1Z;<(UM<3`==@<`,1UPI)QSBOH@'(K^5O_`(*"_L.>./\`@DC^UGI^
MG0ZU<-MVZUX7\06C&&26-9"%)Q]V5&7#`<<@]&Q7ZT?!']H3]L3_`(*+?L3^
M"?&'PNU[X=^$8[RR>SU"\G0R:A?W=NS03.V?DAW21EP%'W7%<>!SJI.4Z%>F
M_:1Z+K^/ZGTO%?AC@L-0P^9Y3BX_5*VG-4=N5V;6J5W>STY;IIIGZ>45^`7C
M7_@KE^V'_P`$O_VGCX3^,-W:>*EMT2XFL+U1)!?V[\"6"=0#C(89'\2D&OOR
MU_X..?@7?_!_2?$EG8^--4U&^@9[S2;#2GN)-)D4X*3R#Y%SC*G^)>>*ZJ&>
M86;E&;Y''=2T9\]FOA;GF%C2JX:*Q%.I\,Z3YH]]=K>NWG<_0&BOSA^$'_!S
MC\`OB-X[LM&U:U\3>%8;Z=;=;^]@#VT)8X#2%>54=S@XK]$M`UZR\4Z):ZEI
MMU;WVGWT2SVUQ!()(IXV`*NK#@@@@@BN_#XRAB$W1DI6['RF<\-YIE,HQS*A
M*GS;76C]'L6]W-+7P7^TS\;?&'A3]IK7);?5+S3VTNX$5K$CD1B(*"OR]#N!
MR?7<:^R_@I\1D^+7PKT7Q"B>6=1@S(G]V16*.![;U;'M7Y]P?XG9?G^;XS)J
M5.5.KAG)>];WHQER.2[6E:Z?=:[V]?B#@O%95@,/F,Y*4*R6WV6US)/O=7LU
MV9U-%%%?I1\:%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!^-W_!
MW/H4$OA#X&ZGM7[5#>ZS:AL<E'2S;'X%/U->\_\`!KP]PW_!,R3SMWEKXNU$
M09Z!/+MB<>V\O^.:^=?^#NGQ;"1\"]"216G!UJ_F3NJ_Z"D9_$B3_ODU]N?\
M$"_AO'\-O^"47PJC\GR[C6;>[UBX/_/1KB\F=&_[]>6/H!7R^'C?.ZLETBOR
MB?N^<5O9>%^!ISWG5=O12JO]/Q/%?^#H7]F_1/B!^PG;_$1K*-?$G@'5K5(;
MQ5_>&TNI!!)"Q[KYCQ,/0K[FOFG_`(-._%UOK/C7XQ>!]2T^QU"QNM/L=9C%
MQ`LGEM'))"X^8'AA*G'^Q7W?_P`'#[1K_P`$A?BOOQN9]&$>?[W]LV/],U\+
M?\&CW@.2\^)?QI\3D$1Z=IFF:6I_O&>6>4_E]G'_`'T*SQ5.V=TW'JKO[I+\
MD=>0XMU?"_'1KO2G4Y8^7O4I*W_;TG][-'_@Y,_X)9^#_A7\/(?CKX!T4:/<
MS:O%9>)K2T4)9[)E98[D(.$/FA$.."95KU'_`(-<?VVO$7QG^#_BKX2^(9DN
MK?X:6]K/H4Y_UPM)Y)P\+'NL;*FT]E?'0"OK+_@M_H,/B/\`X)3_`!HM[A5:
M./1H[H`]GANH95/X,@K\R_\`@TMBE;]IWXK.N[R5\+P*WIN-VN/T#45::P^<
MP]EHIK5??_DF/`XZ6<^&V*68>_/#32A)ZM*\+:^DI1]-#]A?CC^R#X9^.?B=
M=5O+BZL=4\I8Y'@(/FJN=N5/?MGT`KT'X=>`['X8^"=.T'3586>FQ>7'N.68
MDEF8^Y8D_C7X4_\`!:KX._'[_@G!^U'#\6_"WQ1\=7GA'Q9?,;#4)-19O[+N
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MKEGXFT6SU+3[B*[L=0@2YMIXVW)-&ZAD=3W!4@CZT`6J*,T9H`**,T4`%%97
M@KQQH_Q'\,V^M:#J5GK&DWA<07=K*)(9=CLC88<'#*RGW!JAX,^,/A?XA^*?
M$FAZ'KNFZIJ_@^Y2SUJTMY0\NF3.F](Y1_"Q7D#TH`Z2BBLOQAXUTGX?Z!)J
MFN:C9Z5IL,D43W-S((XU>618HU)/&6D=%'J6`H`U**,T4`%%%%`!03BBL?XA
M>/-)^%O@/6O$VO7L.FZ'X?L9M1U"[E^Y;01(9)'/L%4G\*&TE=E0A*<E""NW
MHEW9_/E_P7OU[5_VR_\`@LK;_#7P]F\O-)BTGP;IL:G*&XGQ.Y]L2795C_TS
M]J_?[X*?"S3O@;\'?"O@O2%VZ7X3TFUTBTR,$QP1+$I/N0N3[DU^'G_!$;P!
M<?\`!0?_`(+(_$#X]:A:SPZ'X9U"_P#$R(R[E2ZO9)8K*W8_[$32N".]N/6O
MWJKY[(J?M)5<8_MR=O1?U^!^P>*V*^JTL!PY#_F&I1<U_P!/))7O\E?_`+>9
M^>/_``<Z^.(_"W_!,.\TYI523Q+XFTVP1">9-ADN3@>WD9KG?^#6OX$:A\,_
MV#]>\5:E9O:R>/O$<EU9%UVM/9011PQO]#+]HQ[#/>OF_P#X.9?B3K_[3?[9
MOPI_9]\%6=QK.JZ?;"]-C;<M<:A?/LBC;L/+AB#[C@!9R2<9Q^R7P"^%5K\"
M_@9X-\%V*QK:^$]$L](C*#`800I%N_';G/<FC#P]OFE2MTII1^;W^[4,VQ$L
MJX#PF6/X\7.55KJH*RCI_>M%I^3/G#_@O-XMA\'_`/!)SXOS2RI&UY96EA$"
M>9&FOK>/:/4[68_0&OC?_@TJ^"5[HWPZ^+7Q"NK=X[/7KVQT33Y&7'F?9EFE
MG(/<9N(1QW4UU/\`P==?%=K#]F?X9_#VSF=M2\6>)VU'[+%\TEQ%:P-&%VCD
M@RW4>!W*CTK[8_X)4?LYWO[*7_!/CX7>"=5L3INM:=I`NM4MF`\R"[N9'N9D
M?'5E>4J?]W'04_9^VS?FZ4X_B[_HR8XK^S?#OV'VL96;2Z\D.6[7_;T$OF>&
M_P#!RGIEO?\`_!*;Q5-,JM)8ZSI4UN3U5S=)&2/?8[CZ$UX;_P`&E6E30_LT
M_%>^8-]GN/$UO`A_A+QVJLV/?$B?I7:?\'3_`,7M/\'_`+`N@^$VNXUU?QEX
MHMS!:Y_>2VUK')+-(!_=21K<'WD6O;_^"$'[*]Q^RC_P3:\%6.HV_P!FUSQA
MYGBK4HSU5[L*85/^T+9+<$'HP(J73]IG/-'[,-?G?_,VCBUA/#5T*N]>N^5>
M4>5MKR3C;U9]BU^,_P#P<->`9]6_X*&?#7Q]8K,=2^!7@&+XE0F+.5BL?%VC
M1W3''\*6MS/(>V(S7[,5X1\=/V3OA;\>_CW?7'B;4)6\7^(_AMK'@6;2XM02
M-[G0+Z:$WCB$@L2)$B`D^ZI(!!S7T1^,G\_7PV_:'UKQM^WC^U9\?-'NO*OO
MB!\"?''BW0[F>W2X5;:#7Y+"R.R561U6"PA7#*5.WIBOT"^(/Q#^/7[;'C_6
M]#^'/QV@^",/[//PL\*Z^T<]I;K:^+=7U+3WO3+<,P`BLXXXUC8H,*S-Q_=^
MIQ_P0K_9]\+:#(JP^)-/T^V^%<WPFE;^TT1$T)YGN978F/'GF1W<R].3\M4?
MVGO^"*O[._[<VL?#K6-9U;Q1`=%\+6N@6I\/>(%M(_%NAPA7A@N]J'[3#@YR
MA7(<\_=P`?#WC;]N;]J70OVS?VIO%3_%K2M1\$_LM^`]%\3S^&]-LTET?7=4
MOO#"E1`^P2_8S>/-<G<Q.$0#`S6Q\%OVEOVAOV19?@_XD\9?'"Z^*]G^U=\-
M-?\`$!L39P1GP-JUMHAU6"6V*`AX5!\D[@`",XXY_1/X`_\`!.#X$^"-=^*W
MB#P?I=KJ.B_&/2-/\)^(=+2Z6XT<V.E6;Z9%:1(H^15A#QN"Q.5/0BO./V8O
M^"$OP!_8Y\<>(-2T6\\::C=^*M"O?"NEVNOZ\+V+P[I]T#]HMM,5D!A!4D$Y
M8[1C/+;@#X-_8?\`VD/VKO">M?`?XB?$+XV7GC+2_P!HWX6>,-4CT8V,,2Z'
M<:3IWVBSN%VH`TK@QNQ``W-("I&VO8?B+^VA\8/BA=?\$SO"/A[XN:IX;U#]
MHCX>ZI+XUU2PMK2XN+J__P"$=T^:*\9&0J)(KJ6>0*NU2V01@8'V_P#"/_@G
MS\'_``S%\(;/0)[S5(_V;[#4_"NB0M?QW"P)>VD4%U!>`+\\GDB,X^4C=D@@
MBO'_`-ES_@W6_9__`&1OC_X1^)'AB\^)%YKW@.]NKO08=5\0"ZLM+2XC>-K>
M*+RAMA42.54'.6)+-0!^>O[,]C^T-\,_^";_`.RSX9^%?[0&M:3J'QV^)&H^
M&XUN--M&@\,6D<FL_:/+PC,^]XS<?-R'4`?+D5#^TK_P4<^-W[%T?QO^'=AX
MTO-2\1W/Q8\(_#9O%=GH5NVJ06\FB,]Y=PQQH#-=S21;D$I<C>P&.*_4+X&_
M\$2/@O\`L\^/=+U[P[/XX5=!\7MXUTC3;O6S<:?I%XT5W$8[>)D^2`K>S$H#
MDL5)8D<W_C/_`,$8/@;\?]'^+MGXITG6-0_X7-KEIXEU>?[=LGTW4K6!H+>Z
MLG"YA=(V8<[@=Q!!!(H`_,S7_P#@HA^TM\/OV'_B%X8\-^*?B-9^(O#GQ1\)
MZ1X.\7^-=`CT[4=3L=6$BRV5S"RLI$,\6"X^9HYD.0:J_M'^%OCXW[-G[5WP
M=^('[0GB#Q-)\"_B/X!GCU@:;;JVL6^LW.G3)%("O[M;>6:&=0,_O(=N2AQ7
MZ-?"O_@@U\#/A5\$'\$QR>-M;-YXKTSQCJ&O:OK(NM:U2^TYMUFLTYC`:&/)
M`0*.&/.3FO0/C=_P2J^%?Q_TWX[VOB"/Q#M_:);1I/%;6U^(G232HH8[)[8[
M#Y3)Y$3'.X%EZ8XH`]K^"_@_5/A_\*/#^B:WXGO/&FKZ791V]WKMW#'#/JTB
MC#3ND?R*S'DA>*Z>N3^!?P@L/@!\'?#?@G2[[6=4T_PO81:?;W>K79N[ZY2,
M8#S2D`R2'J6(&3764`%%%%`!7YV?\''/[:$/P/\`V0E^%.DVMYJ/C3XU;M*L
M8;8%F@M8Y8?/8J,EFDWK"B`?,9&/\!!_1.OF?XV_\$QO"W[07[>W@/X[>)=>
MURZN_AS910:1X?`B&GK/'+-*EPYVERP>4/@$?-%'R0-M<684ZM2@Z='>6E^R
M>[^X^GX/QF`P>:4\;F5W"E>:BK^].*O".FR<K7;TLM3-_P"".7[!J?\`!/\`
M_8H\/^&M0M(8?&>N#^V?$\JD,QO)0,0;NXACV1<$J65V'WC7T?\`$KQ_I_PH
M^'6O>*-7D\G2?#>G7&J7LG_/.&")I9#^"J:VP,"O+OVS_P!EZR_;/_9I\3_#
M/4M<UKP[I_BF**&YOM*=%ND1)HY2@W@J5?R]C`CE68=ZUC1]C0]G17PK1'%7
MS!YGFCQF9SM[6=YR2O9-ZV7DMEV21^9W_!$GX0^)_P!OW]OCQ_\`MH^,(X+'
M2Y+^\TKP[I[$R2I*8(X%VM@#RX+1A#NQ\[LQXVFOV"Z"O/?V5OV9/"O['7P%
M\/?#GP7:S6OA_P`.0&*$S/YD]R[,7DFE;`#2.[,S$`#+8````Z3XI>#[GXA?
M#7Q!H-GK%_X?NM;TVYL(=4L2!=::\L3(L\6[(\Q"P9<C&5%8Y?A7AZ'*]9/5
M^<GN>EQ=GT,XS1U:?N48I4Z:M\-..D=%=[:O?5L_(WP=H%Y_P5R_X.`]8\2+
M=6\_PS_9NN((8<_O8KJ2UF<1JF/E8S7HFEW'@Q0`<X&?V0S7A'_!/;_@GUX*
M_P""<WP+7P9X0^T7T]W<->ZMK%XJ_;-6G/`:0J``J+A40<*`3RS,S>ZS(9(F
M56*LPP&'5?>IR_"RI0<JGQR;;^?3Y+0TXRSVAF&*IT,%=8>A"-.G=6;2WDUW
MG*\GUM9/4_$C_@H/X`;_`(+!_P#!=[2/@WI^K-'X-^&&FBUUJYB/F)"L3">_
M*`=)6DEAM<G@/&,\#G]L]-TZ#2-.M[2UB2"VM8UBBC086-%&`H'H``*^8_\`
M@G+_`,$J_!?_``3LF\7:MINK:QXP\9>-KLSZIXBU@(;R2/<7\E=HP%+DNYZN
MY!)PJA?J*HRW"SI\]:JO?F[OR71?)'1QIQ!A\;]6R[+Y-X;#04(MJW-)V<YV
MW7-+H^BZ785\"_M9>/;CX5?\%E])\46D,-Q=>&_V;O%NJ0Q2Y\N5X-4T^55;
M'."5`..U??5>`_'7]@O3?CE^TI-\2+CQ!?6%U-\-=8^&_P!BC@5HQ!J,\,KW
M.XG.]#"`%Z'<<UZ9\.?$/P7_`."M'QT^,6F?#,_%CX=_#"U^'?[1_P`*_$_B
M30K+2+^^;4K9]+L$FF6[=MJ^5<1S*46+YD68`R%D.>+^%NM>(O%G_!27_@FK
MJGA'2?"/AGP[J7P#%W:Z0SW<ZZ79/IUJ]U;1R.S.Q2`QI"TC,25)D+9S7V5I
MG_!'_0],\'_L^Z.OC+5FC^`/@/7O`ME(;./.K1:KI]M9/<2#/R-&MN'"KD$L
M0:@M?^"0R^&_B?\`LI^+/#OQ-US1-2_9A\+0>#44:9;W$?BG35MH+::.97SY
M+2QPD%DR4\S*X90:`/F35_\`@J1_PQ%_P3I\%^(/!MC\+/AI;^*OB5XSTEX=
M;?5M77?;ZUJ(=[6R@+W5S-<SJ&;$B10M/_"A4#B/$W[8OQ2_X*!^+/\`@F]\
M6=/T[P/X?U;Q-XL\46YL[N.[\F/4+./4+*X<K]]87AMF=$.71W`8D`D_6/B'
M_@BM=Z9I/PGN?`GQCUSP1XN^$?B#Q=K>EZXN@66I%U\1W4EQ=Q&"X#1AHPX2
M.3D@`D@YXKZ3_P`$1+CP=\!_V?O"_ASXS^*-)\2?L^^*=7\3Z9XFETFUO+G5
M7U.YNI[E+B*3,9)%U(FX#H2<9.0`<UH7[>EK^R;XO\?ZU9^#=`T?PEJW[43?
M#_QE=1W-R\\K7VD:>L.L%I)&2-EG:VCDC51'Y:Y4*V2W@7CC_@Y.\?:)I7@>
M.ZT'X?\`@>/XH7^OZMH/B'5]/UC5[.T\/V%Y)96K2V>GQR7,MS<S0S'<I2-$
M$;<[^/M#]HK_`((Y^&_VC?V6_CQ\,=0\7:UI\/QO\>+X_;4[:WC^T:#=J-."
MI""<,H_L\#)P<3-T(!KFOBG_`,$28;BW_9^U?X5?%KQ-\(?'W[._A4>#]&UZ
MPTJTU"+5+(P1Q2"ZM)U,<C,5=^3MW3,Q!(4J`>T?\$N_VVIO^"@7[''A_P"(
MU[I<6CZM<7-YIFHV\$<Z6[3VMP\)FA$Z),(9E5)D61%=5E"L-P-?0M>;?LF?
M`O6OV<_@?I?A?Q%\0/%'Q0URWFN+J^\1Z^R?;+Z6>=YF`5`%CB0OLCC7A$55
M'`KTF@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
6****`"BBB@`HHHH`****`"BBB@#_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>footer.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 footer.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`@$!
M`@("`@("`@(#!0,#`P,#!@0$`P4'!@<'!P8'!P@)"PD("`H(!P<*#0H*"PP,
M#`P'"0X/#0P."PP,#/_;`$,!`@("`P,#!@,#!@P(!P@,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`#L`
ME@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/W\HHK\K?\`@O\`?\'!5W_P3E\1V/P;^$>DP^(OC;XBMH9S-<0^
M?::!%.Q6']T#F:YDQE(_NJ"K-N#!2`?J@\JQ#YF5?J<4Y6##(Y'M7YL?L._\
M$1+SXE?#K3?'G[9'B[QA\:?BQX@MQ=76DZGKMS'H?AI9`&%K#:PND32)T9L;
M=W"@!0Q\%_X*[_L2?&S_`()#_!;6?C1^Q]\3O'6@^!=-23_A+?`U_J,FM6.G
M02_)]OLTNO,*+&6&X`[D&'#;0PH`_:'.:*^3?^"%7Q%OOBM_P2+^`VN:EJ%W
MJVHW7AF.*YN[J9IIIY(I9(F+NQ)8Y3J37UE0`4444`%%%%`!1110`4$X%%<7
M\?/V?/"?[3GPYNO"?C33'U71+I@[11W<UK(C@$*ZR1,KJPW$@@\'GM0!V0E4
MG&Y<^F:!(I.-RY],U_.OX1_9OO/V$?\`@[7^'7PZ\/\`B7Q5/X'U*[?6M)L;
M[6+BZ%K;W6E7;-;DR.Q94E611NR=H7))Y/JG[(7Q'UJP_P""V%UYNH:U?VEG
MXK\0R?84N7<3!([UA&J$X).``/7%>-FN<+!5*,'&_M)<N]K;:[:[GZ3P#X=S
MXGPF8XF%=4_J=)U;<O-SV4GRWYER_#OKOL?NM35D5CPRGZ&OS7_8W_X+*77[
M1O[2?Q!\$:GI>O26?BBXFD\+0K8A'T&"*S?SDNF#$J,Q`C`/SN^2`P"_/?\`
MP;L^,-7U[]NGQ##?:KJ5]"OA"\<1W%T\JAOM=F,X8D9Y//O7%'B?#U*U&G07
M,JDI1O>UG&W2VM[W]#Z>IX%YMA,NS+&9I45&>#I4JO+R\W.JBD[*5UR\KBXO
M1^\G;17?[74445],?AYG>,/%5GX%\):IK>I2^1I^CVDM]=2?\\XHD+NWX*I-
M?RZ?\$<=1U#_`(+`?\''J?%3QI%)J-M9ZC?>.9(7&4M(;11'IT.#G"Q.UHH'
M?RZ_HW_X*+Z?>ZM_P3]^.-KIK.M_<>`=<CMRGWO,.GSA<>^:_`#_`(,G6@_X
M>#?%$-M^T?\`"OY/+SUV_P!HV>['_CM`'],E9/C_`,#Z7\3O`NM>&];M8[[1
M_$%C-IU];/\`=G@FC:.1#[%6(_&M:B@#XI_X)\V^A?\`!'G_`():>"_"_P`=
MO%'AOX?6W@V]U73TN]4U6(13POJMY):;6!^=WMWB?8N6&2"`00.V^&__``6B
M_9=^+'C'1]!T7XQ^&6U3Q%*L&E1WL=QI\>I.QPJPR7$:)(22``K'.1CK7C/_
M``5S_P""%T?_``56_:I^#'CC5/'KZ)X7^'3^5K.@/9&X758//6=O*;<%CD?;
MY;%E8;<'G;@R?\'-?@OPU<_\$1_BY_:%CI<?]B0:9+HY>)%-G<#4K5$\CCY&
M*,R87'RLPZ$T`?>7BKQ=I7@7PY=ZQK>IZ?H^DV$?FW-[?7"6]O;I_>>1R%4>
MY(%>._!S_@IA^S_^T)X\U[PSX)^+O@7Q/K'A?3WU758K#4TECLK5'"/,TH_=
M[%9E#$,=NX9QFOG_`/X-N/&VK?&3_@BE\(;KQ9?7'B*Y-OJ.GM+J#FX:2W@U
M"YABC8OG<J1HB`'.%4#M7Y1?\$Z?V4/!OQ)_X.P/C%X9O=#T^3PCX3U_Q+K$
M>B^0BV$C13CR8V@`V-$DLJ.J$;0T2''RB@#]GY?^"Z'[(]OXW@\/R?'CP+'?
M74GE13-/(MC(WH+LI]G_`/(E?56G:C;ZOI\-W:3PW5K=1K+#-"X>.5&&596'
M!!!R".#7Y_\`_!SM\,=%\4_\$2OBXT^GV8D\.II>H:<X@7=9R)J5JN8^/DS&
MSH<8^5V'0UY'_P`&E/B?6OC-_P`$9]6\/ZKK>J>5IGB;5M!TVX$Y:;3;9[>W
MD"Q$_=V//(R@<`F@#[&^*?\`P66_9C^#/Q(UKPCX@^+WAV'Q%X;D:+5K.TAN
M;]M,=3AEG:WB=8RIX(8C!!!QBO6?V<OVM/AG^UYX0DU[X8^.O#/CG287\J:?
M2+Y+C[._]V10=T;>S`&O"/\`@C=_P2GTK_@D]^R]J'@?^W(_&/B#Q!K=UK.L
MZZUIY#7[.0D*[2S$!(43(+'YVD(^]7Y1?\$]Y]/^%G_!X?\`$[P[X(DM=-\+
MZM<ZY;W5EIV([1\:>+F2/8F%^6Z0G&.&4T`?T)WM[#IMI+<7$T=O;PJ7DED8
M*D:CDDD\`#U-?//A7_@KE^S'XV\;Q^'=+^.7PWO-7FNOL,42ZQ&J33YV^6DA
M(C9L\85CDU^*_P#P</?M:>,O^"@/_!8SP/\`L@^&_$NJZ'X$T_6=*\.ZK;VL
M[Q0ZA?WS0O-/,JL!*L,,J*BMD*RR$<M7]`FA?`/P5X<^$=IX#MO"OA\>#;*Q
M33H]&:PB:R^SJH41F(KM(P.<CF@#\8/VP=4M=;_X/%/V=[ZQN+>\L[SPQ:RP
MSP2"2.939:IAE8$@@CN.*^@[C_@G_H/_``3G_;/_`.&D/BK\:OA_X5\&CQ%J
M&H"'4MUI)*;I9]D*,S8>0>:#A02=IP*^'=0_9QT7]E__`(/)?!/A_P`-V:Z7
MX=U"_P#[;L+"(!;>Q%UH]S++'"@XCB\\S,$4`+N(`Q7Z1?\`!6O_`((3P_\`
M!5']KSX->/\`5_'TVC^%?AX!;ZSX<DM#.FJ0"X\\^2V\+'))_JW9E/R!2.5P
M>'&9=0Q4H3K*[@[K5JS_`*1]5P[QGFN1T,5ALMJ*,<5!TZEXQ=X---*Z=M&]
M59FW^SG^VE^Q7XK^-7B>7P#\3/AS:>/OB>91;M/%)I-U?K<(A*H9UC^T!YD:
M4%<DER!5+_@E[_P1X\2?L#?M#ZEXVU?QIH?B&UU#0Y]*6VL[.6&1&DF@D#Y8
MD8`B(Q[BO`_^#Q_P)X/7_@EUX;U&ZM=*M/$6C>,;&WT!UB1+@(T,ZS0QD#=Y
M?E@,5&%S&A/05]'_`/!ME\3->^+'_!&3X.ZIXCU2\UG4H8+^P%U=RM-,T,%_
M<10JS,23MC15&>@4#M6=3*<+.I3JN.L&VK::O?1;G5@O$#/<+@L7E\*[=/%1
MA"IS)2;C!-12;3<;)O9H^Z:***](^+*NNZ):^)=$O--OH5N++4('MKB)ONRQ
MNI5E/L02*_F%_93LT_X-TO\`@XV?P;XBOG;X=Z\_]B#5+@^2AT;4_+DM;E^H
M_<3+&LAZ9@EQBOZA*^//^"M?_!%?X5?\%;_A[:V_BR.?P]XXT.%HM#\5Z?&I
MN[)22WDRJ>)H"W)C8@@DE60DD@'V#%*LT:NC*Z.`RLIR&![BJOB/Q%8^$?#]
M]JVJ7=OI^FZ9;R7=W=3N(XK>*-2SN['@*J@DD]`*_)G]E[P!_P`%+O\`@F+X
M>T_X<V_ACX;_`+4'P[T95MM(OYO$0TK5+&V7A(3+.5;:HQ@.LI4#:'P`*^@K
M?]F/]I;_`(**V4&F_M)2>"_A7\)9'6;4?`'@O4)K_4O$RA@PM=1U%@JI:G'S
MQVX!D&59@O!`/SC_`&TO^#C']ICQ1\5?!_PN^$&G:/X8U#XX7PU'PQJ]_9+-
MJ%IIE[J,UCI:1(_[I/,@MDN6DD5V)NR!M"`U]#?\%E?^"9<7P@_X(Y?&'QO\
M5OBAX]^.?Q.T?2K*6TUCQ)?F+3='G>^MHG:PT^+;!#N5V7<P>3!^\,XKN/\`
M@M7_`,$$?%'[87QV^&_QR^`?B'0/!_Q0^%]M96EIIFI*T.FW<-C,T]GY;1JP
MB>-F*[2NQDVC*[>>C_;(_8V_:Z_X*V_L@:A\*?B9#\+?@;I=Y:BXU)M%U:?7
M9_$=_!^\M8B#$BVME]H6*23#2RG8%'&20#I?^#6W_E"'\(?^NNL?^G6[KX"_
MX)0RA?\`@[J_:0&5^:;Q2!S_`-/<'^%?5?\`P1]_8^_;>_X)_P#[-2_`O4M$
M^$L7AW0-;EU72_%4GB&2X8VKR^?+8);+;LW[Z7<OG/@Q+/(P1V1%/F/[,?\`
MP0D_:X_9E_X*BZ_^U)8^-O@5J?B#Q5JVJ:AJ^AR3ZG%9W,-_([RVZR"W+H%+
M*4?#$&-20PR"`?8/_!R<,_\`!$KX[<A?^)=8]?\`L)VE?$?_``;5_M/6_P"Q
MK_P;U_&KXIS6(U<>`?$>M:N+$2^7]KDCL+(QQ%@#M#N5!;!P#G!K[]_X+2_L
M4?%;_@HU^PI>?!_P'J7@GPW/XLN+23Q!?:Q=W.RWBMYHKD16XBA8ONFC4%GV
MX13P2WR_,/\`P2*_X(;_`!I_8;^!/Q.^!GQ0\2?#3QM\$?BY;7*:K!I5S>PZ
MII<TUJ;=Y+??`$;>JQ`AB-IC5AD@JP!@?\$DK#X__P#!<?X8ZS\;OC9\9/&7
M@OX7:UK4]CHGP_\``<PT6UO+>WPDOG7:9NC"7WQE1('8HQW@$"OEK]A#X5>&
M/@?_`,'BOB/PGX-TNTT7PWH:ZI;V=E;9,</_`!(LORQ+,Q<L69B26))))-?;
M'_!-S]B[]LS_`()/>#_$WP5\'Z+\)?BA\+5U:ZOO!_B36_$,^EW.D).P8BZM
MHX)&D7<2[1H0=Y<"3!7'DEI_P0@_:1_8N_X*<>%?VJ/AQXG\*?&[Q1J%Q<WG
MC73-=N?[!:XNKV&:*[-LX1T6W"R_N@<NFQ00XH`^'O\`@J18R?L/_P#!U/H_
MCSQ8IM_#>I>-?#WBZ*Z;[IL'^SQ2R?\`;-XIQ_VS]Z_J)5@ZAEY5AD$=Z_/3
M_@HS_P`$3YO^"O/[*6CQ_%S4]$\+_''0Y;R[T;6=!C:XL=&CFD9H]-D+*CW5
MNJ"(-(0K&16=0H8H;WP.\3_M^>$O@;9?#/6/AG\'Y/%FBZ>FD6OQ)G\82/IL
MZ1H(TO9-/6`SO,5&XIN16?\`N@XH`^%OVNO&UCJ'_!Y[\'X8?OZ186.G7!'>
M9]+O)!_X[/&*]"_X+A?\%T/CK\)O^"AFC_LG?L^V>AZ#XEUR32M/E\1W=M]K
MO?MFH[#%'`CCRHT598R799"23C;MY\F^.?\`P;L?MB6__!3CPK\?/"7CKP/X
MI\:3WMOXOUSQ!J5RUAI]CJR7#%K&&W"O,UHL"PQKQDIN!V\"OI7_`(*R_P#!
M"+XK?MH_&;X;_M(?#CQ!X-\%_M%>#8[*35=.-W/-HE_<6<OFVTEO<-$)%92`
MI$D85UP#MVY8`\4_X.//^">NC_LW_P#!(Z3QCXW\9>)?BW\9;CQ'I=G<>,/$
MMXS2#S"YFAL;4-Y%G`0F=D2[B%^9FY-?9W_!K<V[_@B/\(_^NNKC_P`JEU7G
M'_!0+_@EG^TM_P`%IOV<;/P_\8=<^'WP;D\+P?VAHN@>';J;6+?5=<"^7]IO
MIWC7RK81F98XH0[+YY9G?:$._P#\$&_V1?VL/^"?OPHTKX)_$O0?A['\.?#&
MK7NI6WB+3M<^U7=U;SK(_P!B2W\H'FZD$OFNRD(&3:<@@`_2ZBBB@`HHHH`*
F***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`__]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
